RP

Ratnavathi Pydah

Active Director Director DIN 07466181
DIN 07466181 First appointment Aug 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2016
Shareholding value •••• Premium profile

About Ratnavathi Pydah

Data last updated:

Ratnavathi Pydah is a Director at Indonex Health Analytics Private Limited (since 2016). The company operates in Healthcare. Indonex Health Analytics Private Limited reported revenue of ₹3.40 Cr (FY 2024).

DIN 07466181
Primary Designation Director
Industry Healthcare
First Appointment 05 Aug 2016
Oldest Company Age 10 yrs
Largest company Indonex Health Analytics Private Limited · ₹3.40 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Aug 20162016₹3.40 Cr (FY 2024)Active

Board colleagues of Ratnavathi Pydah

Directorship timeline

Open interactive timeline →
Indonex Health Analytics Private Limited
Premium access

Shareholding and investment profile for Ratnavathi Pydah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ratnavathi Pydah

Ratnavathi Pydah currently holds 1 directorship: Indonex Health Analytics Private Limited (Director, since 05 Aug 2016, revenue ₹3.40 Cr (FY 2024)).

Ratnavathi Pydah was first appointed on 05 Aug 2016 as Director at Indonex Health Analytics Private Limited.

The current boards of Ratnavathi Pydah's companies include Venkateswara Rao Pydah (Indonex Health Analytics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available